Expert profile

Dr. Erik Escuro

Rheumatologist focused on gout and crystal arthropathies

Gout • crystal arthropathies • urate-lowering therapy • treat-to-target rheumatology care

1Discussion
55 minAnalysed
Last reviewed: Jun 9, 2026·Credential: MD; rheumatologist; WVU Medicine affiliate; regular Project ECHO CME contributor; Healthgrades data shows gout treatment frequency well above peer benchmarks.·First indexed: Jun 9, 2026

Related Health Areas

Topics discussed

About the expert

Focus: Treat-to-target management of gout and crystal arthropathies

Rheumatologist (Conway SC / WVU Medicine) recognized for treating gout substantially more frequently than peer providers. Delivers CME presentations through the WVCTSI Project ECHO program covering crystal arthropathy diagnosis, treat-to-target urate-lowering therapy, allopurinol management, and advanced interventions like pegloticase for severe tophaceous cases. Active in continuing-education delivery to primary care providers serving rural populations.

Expert discussions with Dr. Erik Escuro

Escuro on gout and crystal arthropathies: the CME framework for rural rheumatology
This continuing-medical-education (CME) presentation through the West Virginia Clinical and Translational Science Institute (WVCTSI) Project ECHO covers gout diagnosis, treat-to-target urate-lowering therapy, the related condition of calcium pyrophosphate deposition (CPPD) disease, and the specific care-access challenges of managing crystal arthropathies in rural and underserved settings. The framework is rheumatology-standard but oriented toward primary care clinicians who are often the de facto rheumatologists in their communities.